A detailed history of Foster & Motley Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Foster & Motley Inc holds 4,509 shares of ABT stock, worth $518,670. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,509
Previous 4,556 1.03%
Holding current value
$518,670
Previous $473,000 8.67%
% of portfolio
0.03%
Previous 0.03%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$100.07 - $118.13 $4,703 - $5,552
-47 Reduced 1.03%
4,509 $514,000
Q2 2024

Aug 02, 2024

BUY
$100.73 - $112.44 $35,859 - $40,028
356 Added 8.48%
4,556 $473,000
Q1 2024

Apr 18, 2024

BUY
$109.52 - $120.96 $9,309 - $10,281
85 Added 2.07%
4,200 $477,000
Q4 2023

Feb 01, 2024

SELL
$90.19 - $110.4 $4,419 - $5,409
-49 Reduced 1.18%
4,115 $453,000
Q3 2023

Oct 24, 2023

BUY
$95.53 - $114.62 $12,801 - $15,359
134 Added 3.33%
4,164 $403,000
Q2 2023

Aug 08, 2023

SELL
$100.78 - $112.29 $5,542 - $6,175
-55 Reduced 1.35%
4,030 $439,000
Q1 2023

May 09, 2023

BUY
$96.86 - $114.01 $871 - $1,026
9 Added 0.22%
4,085 $414,000
Q4 2022

Feb 09, 2023

BUY
$95.06 - $111.52 $13,973 - $16,393
147 Added 3.74%
4,076 $447,000
Q3 2022

Nov 04, 2022

BUY
$96.76 - $112.03 $8,611 - $9,970
89 Added 2.32%
3,929 $380,000
Q2 2022

Aug 09, 2022

SELL
$102.07 - $123.37 $9,798 - $11,843
-96 Reduced 2.44%
3,840 $417,000
Q1 2022

Apr 28, 2022

BUY
$114.02 - $139.04 $18,585 - $22,663
163 Added 4.32%
3,936 $466,000
Q4 2021

Jan 25, 2022

BUY
$115.53 - $141.46 $4,390 - $5,375
38 Added 1.02%
3,773 $531,000
Q3 2021

Oct 29, 2021

SELL
$116.66 - $129.06 $15,865 - $17,552
-136 Reduced 3.51%
3,735 $441,000
Q2 2021

Jul 20, 2021

BUY
$105.79 - $124.53 $2,644 - $3,113
25 Added 0.65%
3,871 $449,000
Q1 2021

Apr 26, 2021

BUY
$108.84 - $128.23 $46,257 - $54,497
425 Added 12.42%
3,846 $461,000
Q4 2020

Feb 01, 2021

BUY
$105.0 - $114.42 $44,625 - $48,628
425 Added 14.19%
3,421 $375,000
Q3 2020

Oct 19, 2020

BUY
$91.64 - $111.29 $3,207 - $3,895
35 Added 1.18%
2,996 $326,000
Q2 2020

Jul 20, 2020

SELL
$76.57 - $98.0 $50,689 - $64,876
-662 Reduced 18.27%
2,961 $271,000
Q1 2020

Apr 21, 2020

BUY
$62.82 - $91.86 $27,389 - $40,050
436 Added 13.68%
3,623 $286,000
Q3 2019

Oct 24, 2019

SELL
$81.84 - $88.74 $35,191 - $38,158
-430 Reduced 11.89%
3,187 $267,000
Q1 2019

May 08, 2019

SELL
$66.22 - $80.06 $42,248 - $51,078
-638 Reduced 14.99%
3,617 $289,000
Q4 2018

Jan 30, 2019

SELL
$65.56 - $74.27 $196 - $222
-3 Reduced 0.07%
4,255 $308,000
Q3 2018

Oct 31, 2018

SELL
$60.81 - $73.36 $851 - $1,027
-14 Reduced 0.33%
4,258 $312,000
Q2 2018

Jul 24, 2018

SELL
$57.57 - $63.54 $1,208 - $1,334
-21 Reduced 0.49%
4,272 $261,000
Q1 2018

May 14, 2018

SELL
$56.27 - $63.62 $95,040 - $107,454
-1,689 Reduced 28.23%
4,293 $257,000
Q4 2017

Jan 22, 2018

BUY
$53.68 - $57.47 $16,587 - $17,758
309 Added 5.45%
5,982 $341,000
Q3 2017

Oct 19, 2017

BUY
$48.06 - $53.64 $272,644 - $304,299
5,673
5,673 $303,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Foster & Motley Inc Portfolio

Follow Foster & Motley Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foster & Motley Inc, based on Form 13F filings with the SEC.

News

Stay updated on Foster & Motley Inc with notifications on news.